期刊文献+

E-Cadherin在膀胱移行细胞癌中的表达 被引量:7

E-Cadherin expression in bladder transitional cell carcinorma
原文传递
导出
摘要 目的 探讨E Cadherin在膀胱移行细胞癌中表达的临床意义。 方法 采用免疫组织化学方法 ,检测 6 3例膀胱移行细胞癌石蜡标本E Cadherin表达情况。 结果  6 3例膀胱癌组织标本中E Cadherin表达异常者 42例 (6 7% ) ,异常表达率与膀胱癌的病理分期、分级 ,肿瘤复发和生存率间的差别均有显著性意义。 结论 E Cadherin的异常表达与膀胱癌的恶性程度及复发密切相关 ,可作为判定肿瘤预后和复发的分子生物学指标。 Objective To assess the relation and clinical significance between E-Cadherin expression and the biological behavior of bladder transitional cell carcinoma. Methods Immunohistochemical method was used to detect E-Cadherin in 63 cases of bladder transitional cell carcinoma and 6 normal bladder biopsies as controls.The results were analyzed,and combinated with clinical and pathological data. Results Normal E-Cadherin expression was found in all the 6 normal bladder membranous tissues.Abnormal E-Cadherin expression was found in 42 cases of bladder cancer (66.7%) indicating that abnormal E-Cadherin expression correlates with both increased grade,stage,high recurrence and poor survival. Conclusions E-Cadherin expression is closely related to the malignant progression of bladder cancer.The detect of E-Cadherin expression is helpful in predicting the biological behavior of bladder transitional cell carcinoma.Therefore,E-Cadherin could be used as an useful molecular marker for predicting the progression,recurrence and prognosis of bladder transitional cell carcinoma.
出处 《中华泌尿外科杂志》 CAS CSCD 北大核心 2000年第9期545-546,共2页 Chinese Journal of Urology
关键词 膀胱肿瘤 膀胱移行细胞癌 E-CADHERIN Bladder neoplasm Carcinoma
  • 相关文献

参考文献2

共引文献11

同被引文献34

  • 1孙光 陈志文 等.p53和p16蛋白在膀胱癌中的表达及预后价值[J].中华泌尿外科杂志,1999,37:270-270.
  • 2MAYER B, JOHNSON JP, LEITL F, et al. E-cadherin expression in primary and metastatic gastric cancer:down-regulation correlates with cellular dedifferention and glandular disintegration [J]. Cancer Res, 1993, 53:1690-1695.
  • 3TAKEICHI M. Cadherin cell adhesion receptor as a morphogenetic regulater [J]. Science, 1991, 251: 1451-1455.
  • 4Marzo AMD, Knudsen B, Kirk Chan-Tack, et al. E-cadherin expression as a marker of tumor aggressiveness in routinely processed radical prostatectomy speciments. Urology. 1999,53 (4): 707-713.
  • 5Becket K. F, Atkinson M. J, Reich U, et al. E-cadherin gene mutations provide clues to diffuse type gastric carcinomas. Cancer Res. 1994,54(7) :3845-3852.
  • 6Hong RL, Pu YS, Hsieh TS, et al. Expression of E-cadherin in and exon v6-containing isoforms of CD44 and their prognostic values in human transitional cell carcinoma. J-Urol. 1995,153 (6):2025 -2028.
  • 7Suzuki H, Komiya A, Emi M, et al. Three destinct commonly delected regions of chromosome arm 16q in human primary and metastatic prostate cancers. Genes, Chromosomes & Cancer. 1996,17(6) :225-233.
  • 8Grart J. R, Herman J. G, Lapidus R. G, et al. E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas. Cancer Res. 1995,55 ( 11 ) :5195-5199.
  • 9Lin SS,Hung CF,Tyan YS,et al. Ellagic [correction of ellagica]acid inhibits arylamine Nacetyltransferase activity and DNA adduct formation in human bladder tumor cell lines (T24 and TSGH 8301) [J]. Urol Res,2001,29(6) :371 -376.
  • 10Sato D. Inhibition of urinary of bladder tumors induced by N-bu-ty1-N-(4-hydroxybuty)-nitrosamine in rats by green tea[J]. Int J Urol, 1999,6 (2) :93 - 99.

引证文献7

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部